JARED ANDRE: Open Payments
NPI 1528470291 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,125 in 136 payments from 18 companies in 2025. Trend: 2023 $2,123 · 2024 $3,556 · 2025 $3,125
Food & beverage: $3,125
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $889 |
| AstraZeneca Pharmaceuticals LP | 28 | $762 |
| Lilly USA, LLC | 12 | $270 |
| Novartis Pharmaceuticals Corporation | 13 | $250 |
| Novo Nordisk Inc | 9 | $217 |
| PFIZER INC. | 8 | $172 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $138 |
| Exact Sciences Corporation | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Merck Sharp & Dohme LLC | 2 | $47 |
Products named: AIRSUPRA, JARDIANCE, LEQVIO, LINZESS, UBRELVY, CREON, FARXIGA, Wegovy.
Industry payments across IL — which companies pay providers there.
